CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)

NCT03569579 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System Diseases

Interventions

DRUG: Memantine Tab. 10mg
DRUG: Memantine Tab. 10mg + Donepezil Tab. 10mg

Sponsor

Chong Kun Dang Pharmaceutical